Pat LePore

Patrick G.
LePore was the founder of Boron, LePore & Associates, Inc., founded in 1985, where the titles held included Chairman, President & Chief Executive Officer from 1996 to 2002.
Current jobs include Chairman at Lautus Pharmaceuticals LLC since 2013, Director at Tyme, Inc. since 2015, and Lead Independent Director at VYNE Therapeutics, Inc. since 2021.
Former jobs include Chairman, President & Chief Executive Officer at Par Pharmaceutical, Inc. from 2006 to 2012; Chairman & Chief Executive Officer at Endo Generics Holdings, Inc. from 2011 to 2012; Independent Non-Executive Chairman at Lannett Co., Inc. from 2018 to 2023; Chairman at AgeneBio, Inc.; Vice Chairman at Matinas BioPharma Holdings, Inc. from 2018 to 2021; Chairman at Endo International Plc; Chairman at Endo Pharmaceuticals, Inc.; Independent Director at Tyme Technologies, Inc.; Independent Director at Innoviva, Inc. from 2016 to 2018; Independent Director at PharMerica Corp.
from 2013 to 2017; President-Healthcare Marketing Group at Cardinal Health, Inc. in 2005; and Trustee at Villanova University.
Education includes an MBA from Fairleigh Dickinson University and undergraduate studies at Villanova University.